Aktie 939391 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Charles River Laboratories International, Inc. Börse Stuttgart

Aktien

939391

US1598641074

RV6

Markt geschlossen - Börse Stuttgart
Andere Börsenplätze
 21:59:29 17.05.2024 		% 5 Tage % 1. Jan.
203 EUR -4,83 % Intraday Chart für Charles River Laboratories International, Inc. -2,16 % +0,33 %
15.05. Transcript : Charles River Laboratories International, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:00 AM
13.05. CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : TD Cowen klebt neutral ZM

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Charles River Laboratories International Q1 Non-GAAP Earnings Rise, Revenue Fall; Maintains Full Year 2024 Earnings Guidance
Charles River Laboratories International, Inc. Reports Impairment Charges for the First Quarter Ended March 30, 2024
Charles River Laboratories International, Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024
Earnings Flash (CRL) CHARLES RIVER LABORATORIES INTERNATIONAL Reports Q1 Adjusted EPS $2.27
Stocks Down Pre-Bell Ahead of Latest Earnings Results; Asia, Europe Churn
Earnings Flash (CRL) CHARLES RIVER LABORATORIES INTERNATIONAL Posts Q1 Revenue $1.01B
(CRL) CHARLES RIVER LABORATORIES INTERNATIONAL Expects Fiscal Year 2024 Adjusted EPS Range $10.90 - $11.40
Charles River: Q1 Earnings Snapshot
Charles River Laboratories Announces First-Quarter 2024 Results
Charles River Laboratories International, Inc. Revises Financial Guidance for 2024
China trade heats up, UK rates in view
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids
Charles River Laboratories International : Proxy Supplement Filed April 24, 2024
Charles River Laboratories Files Supplement to Definitive Proxy Statement with the Securities and Exchange Commission
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
Charles River Laboratories International : 2023 Corporate Citizenship Report
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 939391 Aktie
  4. 939391 Aktie
  5. Nachrichten Charles River Laboratories International, Inc.
  6. Andere Sprachen